Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$5.01 - $11.83 $3.49 Million - $8.23 Million
-695,984 Reduced 57.96%
504,829 $5.97 Million
Q3 2022

Nov 14, 2022

BUY
$4.57 - $8.4 $1.14 Million - $2.1 Million
250,000 Added 26.29%
1,200,813 $7.11 Million
Q2 2022

Aug 15, 2022

BUY
$3.74 - $10.66 $2.33 Million - $6.64 Million
622,626 Added 189.72%
950,813 $4.04 Million
Q1 2022

May 16, 2022

BUY
$7.81 - $20.45 $2.56 Million - $6.71 Million
328,187 New
328,187 $3.12 Million
Q1 2021

May 12, 2021

SELL
$41.61 - $54.3 $958,236 - $1.25 Million
-23,029 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$25.27 - $54.9 $581,942 - $1.26 Million
23,029 New
23,029 $1.2 Million
Q3 2020

Nov 16, 2020

SELL
$18.49 - $27.24 $2.61 Million - $3.85 Million
-141,364 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$8.9 - $21.84 $334,640 - $821,184
-37,600 Reduced 21.01%
141,364 $2.75 Million
Q1 2020

May 15, 2020

SELL
$7.14 - $15.99 $704,539 - $1.58 Million
-98,675 Reduced 35.54%
178,964 $1.76 Million
Q4 2019

Feb 14, 2020

SELL
$5.1 - $11.2 $393,108 - $863,296
-77,080 Reduced 21.73%
277,639 $3.08 Million
Q2 2019

Aug 14, 2019

BUY
$6.27 - $8.65 $1.82 Million - $2.51 Million
290,000 Added 448.09%
354,719 $3.07 Million
Q1 2019

May 14, 2019

BUY
$4.02 - $8.04 $260,170 - $520,340
64,719 New
64,719 $520,000
Q3 2018

Nov 14, 2018

SELL
$5.15 - $14.0 $257,500 - $700,000
-50,000 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$8.7 - $16.8 $434,999 - $840,000
50,000 New
50,000 $0

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.